NHS Deploys AI for Early Lung Cancer Detection
Published: 8 December 2023
The NHS Greater Glasgow and Clyde, in collaboration with the Scottish Government, University of Glasgow, and Qure.ai, is implementing an AI-powered chest X-ray reporting solution, qXR, across Glasgow to enhance the early detection of lung cancer.
The NHS Greater Glasgow and Clyde, in collaboration with the Scottish Government, University of Glasgow, and Qure.ai, is implementing an AI-powered chest X-ray reporting solution, qXR, across Glasgow to enhance the early detection of lung cancer. With the goal of improving patient survival, the initiative aims to streamline the patient pathway from GP-referred chest X-rays to CT scans or treatment planning by automatically identifying abnormalities such as masses or lung nodules in X-rays. Lung cancer is a leading cause of death in Scotland, with approximately 5,500 cases diagnosed annually, and the deployment of qXR could potentially expedite patient care journeys from weeks to days. The project, part of a national evaluation of AI in radiology, is supported by the University of Glasgow's Digital Health Validation Lab, and experts emphasize the potential benefits of AI adoption in clinical practice for early cancer detection. The project involves collaboration between healthcare professionals, academia, and industry partners to assess the clinical effectiveness and acceptability of qXR, with funding provided by the Scottish government to support the evaluation. The qXR solution, developed by Qure.ai, utilizes AI to segregate normal chest X-rays and flag abnormalities, allowing clinicians to prioritize patient case reporting. qXR will be applied to approximately 70,000 chest X-rays each year.
Read the full press release from Qure.ai here!
First published: 8 December 2023